Amelogenesis imperfecta-gingival hyperplasia syndrome

Amelogenesis imperfecta-gingival hyperplasia syndrome (also known as gingival fibromatosis with amelogenesis imperfecta, or AI-gingival hyperplasia syndrome) is a rare genetic disorder that affects both the teeth and the gums. The condition is characterized by two main features: amelogenesis imperfecta, a defect in tooth enamel formation that results in teeth that are discolored (often yellow-brown), rough, thin, or abnormally soft, and gingival hyperplasia (also called gingival fibromatosis), which is an overgrowth of the gum tissue that can partially or completely cover the teeth. The enamel defects affect both primary (baby) and permanent teeth, making them more susceptible to damage, sensitivity, and decay. The syndrome primarily affects the oral and dental systems. The gingival overgrowth can cause difficulties with chewing, speech, and dental hygiene, and may also affect the eruption of teeth, particularly in children. The cosmetic appearance of the teeth and gums can also have significant psychosocial impacts on affected individuals. The condition is caused by mutations in the FAM20A gene, which plays a role in biomineralization processes including enamel formation. Treatment is symptomatic and multidisciplinary, typically involving dental and periodontal specialists. Management of gingival hyperplasia often requires surgical reduction (gingivectomy) of the overgrown gum tissue, although regrowth may occur. Dental restorations such as crowns or veneers may be used to protect and improve the appearance of affected teeth. In severe cases, extraction and prosthetic replacement of teeth may be necessary. Regular dental follow-up is essential for monitoring and managing both the enamel defects and gingival overgrowth throughout life.

Common questions about Amelogenesis imperfecta-gingival hyperplasia syndrome